The OpenSpecimen Story
The development of OpenSpecimen started in 2004 as “caTissue” under the caBIG program with funding from the National Cancer Center under the leadership of Dr. Mark Watson and Dr. Rakesh Nagarajan. In 2009, NCI stopped the funding of caBIG and caTissue – leaving the centers using caTissue in a bind. This started our entrepreneurial journey at Krishagni.
As a testament to the power of “open source”, we were able to continue the development of caTissue and provide commercial support to the users. In 2012, it became evident that caTissue needed a complete redesign – both user interface and technical design. This gave birth to “OpenSpecimen” – developed with the latest technologies and a highly configurable user interface.
Today, OpenSpecimen is used in 85+ clinical research centers across 20+ countries including, world leaders like Johns Hopkins, Emory University, Weill Cornell, Oxford University, Cambridge University, University of New South Wales, University of Melbourne, and so forth.